Retinal Vein Occlusion and Diabetic Macular Oedema Trial, Recruiting (NCT01496625)

Retinal Vein Occlusion and Diabetic Macular Oedema Trial, Recruiting NCT01496625 Sponsor: National Eye Institute (NEI) Condition: Retinal Vein Occlusion and Diabetic Macular Oedema

Printed from Voxsanity (voxsanity.com.au) — NCT01496625 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Retinal Vein Occlusion

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are able to understand and sign a consent form, or who are minor children with a parent or legal guardian who can sign on their behalf.
People who have been diagnosed with a retinal eye disease, have eye symptoms that have not yet been diagnosed, or are healthy individuals without retinal disease who could serve as a comparison group (particularly for age-related macular degeneration and diabetic retinopathy).

Who may not be able to join:

People who are unable or unwilling to consent to having at least one blood sample taken from their arm for research purposes.
People who are unable or unwilling to consent to having their NIH medical records and clinical samples used for research.
People who have a serious illness or condition affecting their whole body that would make it difficult to undergo a proper eye examination or receive eye care.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Tiarnan DL Keenan, M.D., National Eye Institute (NEI)

Phone: (301) 402-7635

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT01496625

Sponsor: National Eye Institute (NEI)

Phase: Not Applicable

Status: Recruiting

Condition: Retinal Vein Occlusion and Diabetic Macular Oedema

Trial contact: (301) 402-7635

More information: https://clinicaltrials.gov/study/NCT01496625

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are able to understand and sign a consent form, or who are minor children with a parent or legal guardian who can sign on their behalf.
People who have been diagnosed with a retinal eye disease, have eye symptoms that have not yet been diagnosed, or are healthy individuals without retinal disease who could serve as a comparison group (particularly for age-related macular degeneration and diabetic retinopathy).

Who may not be able to join:

People who are unable or unwilling to consent to having at least one blood sample taken from their arm for research purposes.
People who are unable or unwilling to consent to having their NIH medical records and clinical samples used for research.
People who have a serious illness or condition affecting their whole body that would make it difficult to undergo a proper eye examination or receive eye care.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

National Eye Institute (NEI)

Registry

ClinicalTrials.gov

Start date

18 June 2012

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

The intent is to collect data on a variety of phenotypic parameters and to store biospecimens in a manner that permits a broad array of potential testing and experimentation in the future.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov